M&G Investment Management LTD Biomarin Pharmaceutical Inc Transaction History

M&G Investment Management LTD

  • $28.2 Trillion
  • Q4 2023

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 12, 2021
SELL
$74.73 - $90.69 $104,024 - $126,240
-1,392 Closed
0 $0
Q4 2020

Feb 02, 2021
SELL
$72.61 - $90.2 $854,764 - $1.06 Million
-11,772 Reduced 89.43%
1,392 $122,000
Q3 2020

Oct 26, 2020
BUY
$71.87 - $131.03 $846,053 - $1.54 Million
11,772 Added 845.69%
13,164 $1 Million
Q2 2020

Jul 22, 2020
BUY
$79.55 - $124.22 $110,733 - $172,914
1,392 New
1,392 $171,000

Others Institutions Holding BMRN

# of Institutions
632
Shares Held
185M
Call Options Held
1.63M
Put Options Held
1.2M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track M&G Investment Management LTD Portfolio

Follow M&G Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on M&G Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email